In June 2006, the FDA approved a vaccine for the prevention of HPV-related genomes for girls and women ages 9-26. Since then, much has been written about what has been called a prevention breakthrough. We've included some information here, for the purposes of furthering that disucsion.

 hpv_vaccine_background 

 2007_nejm_hpv_vaccine_and_cervical_lesions

 hpv_confronting_epidemic_urologists_perspective

 theoretical_impact_of_hpv_vaccine